08045800513
Send Inquiry
Send InquiryEpalrestat 50 mg
MOQ : 15-30 Boxes
Epalrestat 50 mg Specification
- Drug Type
- Specific Drug
- Ingredients
- Glimepride 2 mg + Pioglitazone 30 mg (SR)
- Physical Form
- Tablets
- Function
- Other
- Recommended For
- Diabetic Neuropathy
Epalrestat 50 mg Trade Information
- Minimum Order Quantity
- 15-30 Boxes
- Sample Policy
- Sample costs shipping and taxes has to be paid by the buyer
- Packaging Details
- Alu-Alu, 10*10 Packing
- Main Export Market(s)
- Western Europe, Australia, North America, Eastern Europe, Middle East, Central America, South America, Asia, Africa
- Main Domestic Market
- All India
- Certifications
- WHO-GMP
About Epalrestat 50 mg
Epalrestat 50 mg is a specialized pharmaceutical solution designed for the effective management of diabetic neuropathy, a common complication of diabetes affecting nerve function. Tailored for adults and aged individuals, this specific drug aids in alleviating symptoms associated with diabetic nerve damage. Each tablet contains 50 mg of Epalrestat, a potent active ingredient known for its ability to inhibit aldose reductase, thereby reducing oxidative stress and preventing nerve damage caused by high glucose levels. As an exporter, manufacturer, and supplier, this product is developed to meet therapeutic needs, ensuring quality and efficacy suitable for global healthcare standards. Epalrestat 50 mg is a trusted and targeted solution for improving the quality of life of diabetic patients dealing with neuropathy.
FAQs of Epalrestat 50 mg:
Q: What is Epalrestat 50 mg recommended for?
A: Epalrestat 50 mg is recommended for the treatment of diabetic neuropathy, a nerve damage condition associated with diabetes.Q: Who is this drug suitable for?
A: It is suitable for adults and aged individuals dealing with diabetic neuropathy symptoms.Q: What is the key ingredient in this product?
A: The key ingredient is 50 mg of Epalrestat, a specific therapeutic agent.Q: How does Epalrestat 50 mg work?
A: Epalrestat works by inhibiting aldose reductase, reducing oxidative stress, and preventing nerve damage caused by high glucose levels.Q: Is Epalrestat 50 mg manufactured for global healthcare needs?
A: Yes, it is manufactured with high-quality standards sufficient for export and supplying global healthcare markets.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Diabetic Tablets Category
Voglibose 0.2 mg & 0.3 mg
Minimum Order Quantity : 1530 Boxes
Function : Other
Recommended For : To enhance Glycaemic Control
Drug Type : Specific Drug
Physical Form : Tablets
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Metformin-500 mg, Glibenclamide 5 mg & Pioglitazone 15 mg
Minimum Order Quantity : 1530 Boxes
Function : Other
Recommended For : 3rd line treatment for Type 2 Diabetes Mellitus, when all other treatment fails
Drug Type : Specific Drug
Physical Form : Tablets
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Glimperide, Metformin & Pioglitazone Combination (Extended Release)
Minimum Order Quantity : 1530 Boxes
Function : Other
Recommended For : Management of Type 2 diabetes (NIDDM)
Drug Type : Specific Drug
Physical Form : Tablets
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Glimepride 2 mg & Pioglitazone 30 mg (SR)
Minimum Order Quantity : 1530 Boxes
Function : Other
Recommended For : Management of Type 2 diabetes (NIDDM)
Drug Type : Specific Drug
Physical Form : Tablets
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Contact Details
- Call us-9877184734, 6283732271, Plot No. 364, Industrial Area, Phase-1,Chandigarh - 160002, India
- Phone : 08045800513
GST : 04AAHCS5485R1ZJ
- Mr Sanjeev Kumar Sethi (Managing Director)
- Mobile : 08045800513
- cmd@solitairegroup.in
- Mobile :+919815777744
SOLITAIRE PHARMACIA PVT. LTD.
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
